Form 4 for RIGL RIGEL PHARMACEUTICALS INC
Accepted 2025-12-29 00:00:00 ET · period of report 2025-12-22 · accession 0000905148-25-004492 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-29 | 2025-12-22 | RIGL | Schorno Dean L | EVP, CFO | M - OptEx | $21.51 | +6,500 | 59.7K | +12% | +$139.8K |
| DM | 2025-12-29 | 2025-12-22 | RIGL | Schorno Dean L | EVP, CFO | M - OptEx | $0.00 | -6,500 | 10.8K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-22 | M | A | 1,667 | $18.70 | 64,235 | D | — | — | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. |
| 2 | Common | Common Stock | 2025-12-22 | M | A | 2,846 | $24.20 | 62,568 | D | — | — | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. |
| 3 | Common | Common Stock | 2025-12-22 | M | A | 1,987 | $20.00 | 59,722 | D | — | — | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F2) Includes 500 shares of common stock acquired under the Issuer's stock purchase plan. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2025-12-22 | M | D | 1,987 | $0.00 | 14,262 | D | $20.00 · — to 2029-01-23 | 1,987 Common Stock | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F3) The shares of common stock subject to the option vested in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2019, subject to the reporting person's continuous service to the Issuer through each such period. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2025-12-22 | M | D | 2,846 | $0.00 | 17,153 | D | $24.20 · — to 2030-02-06 | 2,846 Common Stock | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F4) The shares of common stock subject to the option vested in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2020, subject to the reporting person's continuous service to the Issuer through each such period. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2025-12-22 | M | D | 1,667 | $0.00 | 10,832 | D | $18.70 · — to 2033-01-26 | 1,667 Common Stock | (F1) These numbers have been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024. (F5) The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer through each such period. |